New Mexico Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 15 (94% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 4,303
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 82.03%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,190
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 24.05%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 13.64% 63.70%
White, Hispanic/Latino Patients 48.20% 15.55%
Black/African American, Non-Hispanic/Latino Patients 0.86% 0.34%
Black/African American, Hispanic/Latino Patients 0.19% 0.17%
Asian Patients3 0.58% 0.00%
American Indian/Alaska Native Patients3 6.09% 0.59%
Native Hawaiian/Other Pacific Islander Patients3 0.02% 0.00%
Patients with More than one race3 0.88% 0.76%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.44% 2.77%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.67% 2.18%
Unreported/Refused to Report Race and Ethnicity 23.43% 13.95%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 873
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 82.81%
COVID-19 Immunization Series Completed 1,221
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 85.52%
COVID-19 Immunization Series Additional 1,231
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 64.10%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 13.75% 12.37% 29.16%
White, Hispanic/Latino Patients 53.49% 60.11% 42.00%
Black/African American, Non-Hispanic/Latino Patients 1.15% 2.29% 0.41%
Black/African American, Hispanic/Latino Patients 0.46% 0.41% 0.00%
Asian Patients3 0.57% 0.49% 0.49%
American Indian/Alaska Native Patients3 6.19% 4.83% 0.49%
Native Hawaiian/Other Pacific Islander Patients3 0.46% 0.25% 0.08%
Patients with More than one race3 0.80% 0.90% 1.30%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.09% 3.77% 7.31%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.26% 0.49% 2.84%
Unreported/Refused to Report Race and Ethnicity 18.79% 14.09% 15.92%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 20.00%
1 to 24 Hours 40.00%
More Than 24 Hours 40.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 6.67%
Staffing to administer the vaccine 13.33%
Vaccine confidence 40.00%
Vaccine storage capacity 6.67%
Vaccine supply 0.00%
Other 0.00%
None 46.67%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 13.33%
Average Percent of Health Center Visits Conducted Virtually 26.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 26.67%
Number of Mobile Van Sites 13
Number of Pop-up Clinics 10
Number of School-Based Vaccination Sites 4

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 60.00%
None 40.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 20.00%
Patient awareness/education 6.67%
Staffing capacity 20.00%
Therapy administration/onsite logistics 6.67%
Other 6.67%
None 60.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021